Avesta Pharma Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is POLYETHYLENE GLYCOL 3350 USP, with a corresponding US DMF Number 27419.
Remarkably, this DMF maintains an Active status since its submission on August 12, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 05, 2014, and payment made on September 26, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II